Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > ----LETS GO VAXILBIO-----

<< Previous

Bullboard Posts

Next >>

Post by threefiftynineon Jun 11, 2020 3:26pm

109 Views

Post# 31140025

----LETS GO VAXILBIO-----

Lets get this private placement closed (or at least approved) and get the news flowing---- and while we're at it tell your PP broker to buy more than $170 worth of shares ----This is becoming borderline embarrassing

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December